Directorate Change
Dr Al Musella stepping down from Board effective 31 December 2025, becoming Medical Advisor to subsidiary.
Select text to share a quote on X · sign in to keep highlights & notes in your IBAI notes
The Company announces that Dr Al Musella will step down from the Board of Directors with effect from 31 December 2025.
Although Dr Musella will no longer serve on the IBAI Board, he will remain closely involved with IBAI's wholly owned subsidiary, Imaging Biometrics LLC in a more direct and frequent capacity. Dr Musella will assume the role of Medical Advisor, providing clinical insight and strategic input to product development and marketing efforts.
The Board looks forward to continuing its collaboration with Dr Musella in this enhanced advisory role and thanks him for his ongoing commitment to the business.
The Directors of the Company accept responsibility for the contents of this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.